1例急性心肌梗死合并三尖瓣修补术患者的抗栓治疗及药学监护 |
投稿时间:2022-04-29 修订日期:2023-04-24 点此下载全文 |
引用本文:刘玉兰,刘梅,鲁毅,毕慧,许桂丽.1例急性心肌梗死合并三尖瓣修补术患者的抗栓治疗及药学监护[J].药学实践杂志,2023,41(12):760~762 |
摘要点击次数: 358 |
全文下载次数: 616 |
|
基金项目:南京药学会-常州四药医院药学科研基金(2020YX006) |
|
中文摘要:目的 探讨急性心梗经皮冠状动脉介入治疗(PCI)支架术后合并三尖瓣修补术患者的抗栓治疗方案。方法 评估患者出血和栓塞风险,查阅相关资料、利用药学专业知识,参与整个治疗过程,为患者制定个体化用药方案。结果 通过实施药学监护,对患者进行用药教育,取得较好的治疗效果。结论 临床药师开展抗栓药物方面的药学监护,可提高患者安全用药水平,为临床合理用药提供参考。 |
中文关键词:药学监护 三尖瓣修补术 支架术后 抗血小板 抗凝 |
|
Pharmaceutical care in a case of myocardial infarction complicated with antithrombotic therapy after tricuspid valve repair |
|
|
Abstract:Objective To investigate the antithrombotic therapy for acute myocardial infarction patients after PCI stenting combined with tricuspid valve repair. Methods The risk of bleeding and embolization was evaluated, relevant data were reviewed, professional knowledges of pharmacy were utilized through the whole treatment process, individualized medication plan for patients was designed and used. Results A better therapeutic effect was achieved through the implementation of pharmaceutical care and medication education to the patients. Conclusion Clinical pharmacists carry out pharmaceutical care in antithrombotic drugs utilities,which could improve the safety level of drug use and provide basis for clinical rational drug use. |
keywords:pharmaceutical care tricuspid valve repair stenting antiplatelet anticoagulation |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |